Reply to letter: Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel

Parkinsonism Relat Disord. 2016 Apr:25:114-5. doi: 10.1016/j.parkreldis.2015.11.017. Epub 2015 Nov 22.

Authors

Massimo Marano¹, Gaetano Salomone¹, Lazzaro di Biase¹, Vincenzo Di Lazzaro¹, Jean-Marc Melgari²

Affiliations

¹ Movement Disorder Center, Neurology, Campus Bio-Medico of Rome University, Rome, Italy.
² Movement Disorder Center, Neurology, Campus Bio-Medico of Rome University, Rome, Italy; Movement Disorder Service, Neurology, Azienda ospedaliera di Treviglio, Treviglio, BG, Italy. Electronic address: jmmelgari@tiscali.it.

PMID: 26698016
DOI: 10.1016/j.parkreldis.2015.11.017

No abstract available

Keywords: Behavior; Dopamine agonist withdrawal syndrome; DuoDopa; Impulse control disorder (ICD); Punding.

Publication types

Letter
Comment

MeSH terms

Antiparkinson Agents / administration & dosage*
Carbidopa / administration & dosage*
Humans
Levodopa / administration & dosage*
Male
Parkinson Disease / drug therapy*

Substances

Antiparkinson Agents
Levodopa
Carbidopa